ВОИС - Поиск по национальным патентным фондам и фондам PCT

1.WO/2018/111324METHODS AND INGESTIBLE DEVICES FOR THE REGIO-SPECIFIC RELEASE OF TLR AGONISTS AT THE SITE OF GASTROINTESTINAL TRACT DISEASE

WO - 21.06.2018

Класс МПК A61K 9/00 № заявки PCT/US2017/025086 Заявитель PROGENITY INC. Изобретатель JONES, Mitchell Lawrence

This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a TLR agonist.

2.WO/2018/182623METHODS AND INGESTIBLE DEVICES FOR THE REGIO-SPECIFIC RELEASE OF CHST15 INHIBITORS AT THE SITE OF GASTROINTESTINAL TRACT DISEASE

WO - 04.10.2018

Класс МПК A61K 9/00 № заявки PCT/US2017/025049 Заявитель PROGENITY INC. Изобретатель JONES, Mitchell Lawrence

This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a CHST15 inhibitor.

3.WO/2018/111329METHODS AND INGESTIBLE DEVICES FOR THE REGIO-SPECIFIC RELEASE OF IL-1 INHIBITORS AT THE SITE OF GASTROINTESTINAL TRACT DISEASE

WO - 21.06.2018

Класс МПК A61K 9/00 № заявки PCT/US2017/025143 Заявитель PROGENITY INC. Изобретатель JONES, Mitchell Lawrence

This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with an IL-1 inhibitor. An embodiment of the disclosure relates to releasing the IL- 1 inhibitor at a location in the gastrointestinal tract of a subject that is proximate to one or more sites of disease, by administering an orally ingestible delivery device comprising such IL-1 inhibitor, said device comprise of an ingestible housing comprising a reservoir that contains the IL-1 inhibitor, a detector coupled to the ingestible housing, a valve system in fluid communication with the reservoir, and a controller communicably coupled to the valve and the detector.

4.WO/2018/111322METHODS AND INGESTIBLE DEVICES FOR THE REGIO-SPECIFIC RELEASE OF INTEGRIN INHIBITORS AT THE SITE OF GASTROINTESTINAL TRACT DISEASE

WO - 21.06.2018

Класс МПК A61K 9/00 № заявки PCT/US2017/025059 Заявитель PROGENITY INC. Изобретатель JONES, Mitchell Lawrence

This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with an integrin inhibitor.

5.WO/2018/182612METHODS AND INGESTIBLE DEVICES FOR THE REGIO-SPECIFIC RELEASE OF STEM CELLS AT THE SITE OF GASTROINTESTINAL TRACT DISEASE

WO - 04.10.2018

Класс МПК A61K 35/545 № заявки PCT/US2017/024997 Заявитель PROGENITY INC. Изобретатель JONES, Mitchell Lawrence

This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a stem cell.

6.WO/2018/111328METHODS AND INGESTIBLE DEVICES FOR THE REGIO-SPECIFIC RELEASE OF TNF INHIBITORS AT THE SITE OF GASTROINTESTINAL TRACT DISEASE

WO - 21.06.2018

Класс МПК A61M 31/00 № заявки PCT/US2017/025119 Заявитель PROGENITY INC. Изобретатель JONES, Mitchell Lawrence

This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a TNF inhibitor.

7.WO/2018/111326METHODS AND INGESTIBLE DEVICES FOR THE REGIO-SPECIFIC RELEASE OF IMMUNOSUPPRESSANTS AT THE SITE OF GASTROINTESTINAL TRACT DISEASE

WO - 21.06.2018

Класс МПК A61K 9/00 № заявки PCT/US2017/025116 Заявитель PROGENITY INC. Изобретатель JONES, Mitchell Lawrence

This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with an immunosuppressant.

8.WO/2018/111323METHODS AND INGESTIBLE DEVICES FOR THE REGIO-SPECIFIC RELEASE OF SMAD7 INHIBITORS AT THE SITE OF GASTROINTESTINAL TRACT DISEASE

WO - 21.06.2018

Класс МПК A61K 9/00 № заявки PCT/US2017/025082 Заявитель PROGENITY INC. Изобретатель JONES, Mitchell Lawrence

This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a SMAD7 inhibitor.

9.WO/2018/111321METHODS AND INGESTIBLE DEVICES FOR THE REGIO-SPECIFIC RELEASE OF IL-12/IL-23 INHIBITORS AT THE SITE OF GASTROINTESTINAL TRACT DISEASE

WO - 21.06.2018

Класс МПК A61K 9/00 № заявки PCT/US2017/025053 Заявитель PROGENITY INC. Изобретатель JONES, Mitchell Lawrence

This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with an IL-12/IL-23 inhibitor. An embodiment of the disclosure relates to releasing the IL-12/IL-13 inhibitor at a location in the gastrointestinal tract of a subject that is proximate to one or more sites of disease, by administering an orally ingestible delivery device comprising such IL-12/IL-23 inhibitor, said device comprise of an ingestible housing comprising a reservoir that contains the IL-12/IL-23 inhibitor, a detector coupled to the ingestible housing, a valve system in fluid communication with the reservoir, and a controller communicably coupled to the valve and the detector.

10.WO/2018/111327METHODS AND INGESTIBLE DEVICES FOR THE REGIO-SPECIFIC RELEASE OF JAK INHIBITORS AT THE SITE OF GASTROINTESTINAL TRACT DISEASE

WO - 21.06.2018

Класс МПК A61K 9/00 № заявки PCT/US2017/025117 Заявитель PROGENITY INC. Изобретатель JONES, Mitchell Lawrence

This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a JAK inhibitor.

1 / 409 033

Перейти к вводу поиска	`CTRL` + `SHIFT` +
Перейти к результатам (выбранная запись)	`CTRL` + `SHIFT` +
Перейти к результатам (выбранная вкладка)	`CTRL` + `SHIFT` +
Перейти на следующую страницу	`CTRL` +
Перейти на предыдущую страницу	`CTRL` +

Перейти к следующей записи / изображению	/
Перейти к предыдущей записи / изображению	/
Прокрутить вверх	`Page Up`
Прокрутить вниз	`Page Down`
Прокрутить до верха	`CTRL` + `Home`
Прокрутить до низа	`CTRL` + `End`

Идет обработка

Переходы на национальную фазу

Файл международного органа

Настройки

Обратная связь

Перейти к заявке

Сохранить запрос

Дерево запросов

Уточнить параметры

Полный запрос

Ярлыки к параллельному просмотру

Анализ

Перейти к следующей вкладке
Перейти к предыдущей вкладке